ClinicalTrials.gg
RecruitingNCT06756646Updated Oct 21, 2026

Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD

An interventional study of Aerobic exercise intervention and Disease and exercise suggestion in Chronic Obstructive Pulmonary Disease, sponsored by National Cheng Kung University. Recruiting at 1 site in Taiwan. Open to participants aged 30 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by National Cheng Kung University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.
Updated Oct 21, 2026Primary outcomes revised1 site added+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
30 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 158 studies in Pulmonary Disease, Chronic Obstructive with a site in Taiwan — 28 open to participants now, 30 under way, 6 of them phase 3. Pulmonary Disease, Chronic Obstructive · Taiwan.

Planned enrollment
72nd of 124
90 · median 139
Started
2024
with 9 others
No phase
51 of 158
13 open now
Primary completion
2028-12
later than 23 of 29 live
Registered
135th of 158
by date

Among the 158 studies in Pulmonary Disease, Chronic Obstructive with a site in Taiwan, this one is the 72nd largest by planned enrollment of the 124 interventional ones that give a count, is one of 10 that started in 2024, is one of 51 with no phase, reaches primary completion later than 23 of the 29 other live ones, and was the 135th registered.

Pulmonary Disease, Chronic Obstructive

5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

28 of the 158 studies in Pulmonary Disease, Chronic Obstructive with a site in Taiwan are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.

This study: 30 Years to 85 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 158 studies in Pulmonary Disease, Chronic Obstructive with a site in Taiwan, or all of them as a file.
02

Study summary

Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.

Read the detailed description

The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.

The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.

03

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • Blood flow restriction training
  • Chronic Obstructive Pulmonary Disease
04

Who can participate

Ages eligible
30 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. classified as levels 2-4.
  2. Stable condition without worsening in the past three months.
  3. No participation in any rehabilitation program within the past six months.
  4. Ability to understand and follow verbal commands and cooperate with an exercise training program.

Exclusion criteria

Exclusion Criteria:

  1. Unconscious or unable to cooperate with the evaluator.
  2. Hospitalization due to acute illness within the past three months.
  3. Severe joint diseases or history of lower limb surgery.
  4. Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
  5. Dependence on oxygen supply.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Active comparator
    Usual care group

    The Usual care group will receive COPD and exercise-related education.

    Behavioral: Disease and exercise suggestion

  • Experimental
    Aerobic exercise group-cycling

    The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months.

    Behavioral: Aerobic exercise intervention

  • Experimental
    BFR group-cycling + BFR

    The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months.

    Behavioral: Blood flow restriction (BFR) intervention

Interventions

  • BehavioralAerobic exercise intervention

    The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period.

  • BehavioralDisease and exercise suggestion

    The participants will be provided by educational program about COPD self-care and home-based exercise approach.

  • BehavioralBlood flow restriction (BFR) intervention

    Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period.

06

What researchers measure

Primary outcomes

  1. Oxygen consumption (VO2)

    Oxygen consumption examined by cardiopulmonary exercise test

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  2. Functional capacity

    Functional capacity examined by 6MWT

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

Secondary outcomes

  1. Heart Rate Variability

    Heart Rate Variability examined by autonomic nervous system

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  2. Pulmonary function test

    Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio.

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  3. Maximum respiratory pressure

    Maximum respiratory pressure examined by pressure meter

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  4. Quality of life score (COPD-related questionnaire-I)

    Quality of life score examined by mMRC Questionnaire.

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  5. Quality of life score (COPD-related questionnaire-II)

    COPD Assessment Test (CAT) questionaire

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  6. Quality of life score (COPD-related questionnaire-III)

    St George's Respiratory Questionnaire (SGRQ)

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

  7. Diaphragm capacity

    Diaphragm capacity examined by diaphragmatic ultrasound

    Time frame: Change from baseline (0 week) to follow up (20 weeks)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Huang YT, Cheng HC, Yang HL, Hung CH, Wu TY, Kuo CW, Wang SY, Tsai KL. Efficacy of blood flow restriction combined with low-intensity aerobic training in patients with COPD: Study protocol for the BREATH randomized controlled trial. Contemp Clin Trials. 2026 Oct 22:108515. doi: 10.1016/j.cct.2026.108515. Online ahead of print. PubMed 42914006 ↗

Individual participant data

Plan to share: No — IPD sharing plan will be decided after summarized data being published.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Dec 2028, 49 months after the start.

Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 49 months is above that.

Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2024
First posted
Jan 3, 2025
StartActual
Nov 20, 2024
Primary completionEst.
Dec 31, 2028
CompletionEst.
Dec 31, 2030
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
1 site added, 1 site removed
Show site
  • National Cheng Kung University Hostipal · Tainan, Taiwan
Show 1 removed
  • National Cheng Kung University Hostipal · Tainan, Taiwan
Oct 2, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedDiaphragmFunctional capacityTime frame: Change from baseline (0 week) to follow up (20 weeks)
Oct 21, 2026
Secondary outcomes
1 edited
What changed in the outcomes
  • EditedFunctionalDiaphragm capacityTime frame: Change from baseline (0 week) to follow up (20 weeks)
Oct 21, 2026
Show all 2 updates
  1. Oct 21, 2026
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedDiaphragmFunctional capacityTime frame: Change from baseline (0 week) to follow up (20 weeks)
    Secondary outcomes 1 edited
    What changed in the outcomes
    • EditedFunctionalDiaphragm capacityTime frame: Change from baseline (0 week) to follow up (20 weeks)
    + 1 other change: site details
  2. Oct 2, 2026
    1 site added, 1 site removed
    Show site
    • National Cheng Kung University Hostipal · Tainan, Taiwan
    Show 1 removed
    • National Cheng Kung University Hostipal · Tainan, Taiwan
    + 4 other changes: identifiers, verification date, oversight details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06756646
Lead sponsor
National Cheng Kung University
Responsible party
Kun-Ling Tsai (Professor and Chair, Department of Physical Therapy, National Cheng Kung University) — Principal investigator
First posted
Jan 3, 2025
Start date
Nov 20, 2024
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2030 (estimated)
Last update
Oct 21, 2026

Study contacts

Kun-Ling Tsai, Ph.D.
Contact
kunlingtsai@mail.ncku.edu.tw
886-6-2353535 ext. 5078
Yu-Ting Huang, M.S.
Contact
t66061053@pt.ncku.edu.tw
886-6-2353535 ext. 5078
Kun-Ling Tsai, Ph.D.
principal investigator · Department of Physical Therapy, National Cheng Kung University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion